Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies | MicrobiomeTrials
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2021-10-19Est. Completion: 2033-12-30
Enrollment target: 60 participants
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States